Precipio Inc PRPO:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/24/21 EST
2.72quote price arrow up+0.06 (+2.26%)
Volume
256,800
52 week range
0.55 - 8.00

...

Loading . . .

KEY STATS

  • Open2.67
  • Day High2.82
  • Day Low2.66
  • Prev Close2.72
  • 52 Week High8.00
  • 52 Week High Date07/30/20
  • 52 Week Low0.55
  • 52 Week Low Date04/24/20
  • Market Cap46.87M
  • Shares Out17.23M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.67
  • 1 Year % Change74.36

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-1.61
  • Fwd P/E (NTM)-6.33
  • EBITDA (MRQ)-8.472M
  • ROE (MRQ)-109.04%
  • Revenue (MRQ)4.84M
  • Gross Margin (MRQ)13.52%
  • Net Margin (MRQ)-258.52%
  • Debt To Equity (MRQ)8.49%

EVENTS

  • Earnings Date03/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Precipio Inc News

There is no recent news for this security.

Latest PRPO News From Our Partners

QUOTE FINDER

Profile

MORE
Precipio, Inc. is a cancer diagnostics company providing diagnostic products and services to the oncology market. The Company’s platform is designed to provide physicians and their patients access to necessary technology in order to provide diagnoses. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a proprietary culture media that addresses the problem of selective culturing-by creating a universal...
Douglas Fisher M.D.
Chairman
Ilan Danieli
President
Ahmed Sabet
Chief Operating Officer
Carl Iberger
Chief Financial Officer
Address
12325 Emmet St
Omaha, NE
68164-4243
United States